{"title":"预测高危前列腺癌患者根治性前列腺切除术后尿失禁的nomogram模型的建立与验证。","authors":"Kaiqiang Chen, Weihua Liu, Jian Wu, Renqiang He, Shanghuan Xie, Yaowu Su","doi":"10.62347/ZYAA3728","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To develop a risk stratification model for predicting urinary incontinence following radical prostatectomy (RP) in high-risk prostate cancer patients based on their clinicopathological characteristics.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 520 prostate cancer patients who underwent RP between January 2016 and January 2024. Baseline characteristics, pathological data, laboratory parameters, and surgery-related factors were collected. Urinary continence status at 1, 3, and 6 months postoperatively was assessed. Multivariate logistic regression analyses were performed to identify independent risk factors, and nomograms were constructed to predict urinary incontinence risk at each time point.</p><p><strong>Results: </strong>Urinary incontinence rates at 1, 3, and 6 months postoperatively were 92.88%, 69.62%, and 23.65%, respectively. At 1 month, a higher Gleason score (OR=2.178, P=0.003) was a risk factor, while robot-assisted surgery was protective (OR=0.289, P=0.003). At 3 months, higher Gleason score (OR=1.565, P=0.004) increased risk, whereas lower BMI (<25 kg/m<sup>2</sup>) (OR=0.448, P=0.005) and longer preoperative membranous urethral length (≥14 mm) (OR=2.368, P<0.001) were protective. At 6 months, shorter membranous urethral length (<14 mm) (OR=3.622, P<0.001), neoadjuvant hormone therapy (OR=5.783, P<0.001), and higher Gleason score (OR=2.824, P<0.001) were risk factors, while lower BMI (OR=0.317, P<0.001), smaller prostate volume (<40 mL) (OR=0.591, P=0.044), and lower CONUT score (<4) (OR=0.372, P<0.001) were protective. The nomograms showed good predictive performance, with AUCs of 0.679 at 3 months and 0.818 at 6 months.</p><p><strong>Conclusions: </strong>The developed nomograms effectively stratify the risk of urinary incontinence following RP in high-risk patients, facilitating individualized perioperative management and rehabilitation strategies.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"15 7","pages":"3017-3034"},"PeriodicalIF":2.9000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344162/pdf/","citationCount":"0","resultStr":"{\"title\":\"Development and validation of nomogram models for predicting urinary incontinence following radical prostatectomy in high-risk prostate cancer patients.\",\"authors\":\"Kaiqiang Chen, Weihua Liu, Jian Wu, Renqiang He, Shanghuan Xie, Yaowu Su\",\"doi\":\"10.62347/ZYAA3728\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To develop a risk stratification model for predicting urinary incontinence following radical prostatectomy (RP) in high-risk prostate cancer patients based on their clinicopathological characteristics.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 520 prostate cancer patients who underwent RP between January 2016 and January 2024. Baseline characteristics, pathological data, laboratory parameters, and surgery-related factors were collected. Urinary continence status at 1, 3, and 6 months postoperatively was assessed. Multivariate logistic regression analyses were performed to identify independent risk factors, and nomograms were constructed to predict urinary incontinence risk at each time point.</p><p><strong>Results: </strong>Urinary incontinence rates at 1, 3, and 6 months postoperatively were 92.88%, 69.62%, and 23.65%, respectively. At 1 month, a higher Gleason score (OR=2.178, P=0.003) was a risk factor, while robot-assisted surgery was protective (OR=0.289, P=0.003). At 3 months, higher Gleason score (OR=1.565, P=0.004) increased risk, whereas lower BMI (<25 kg/m<sup>2</sup>) (OR=0.448, P=0.005) and longer preoperative membranous urethral length (≥14 mm) (OR=2.368, P<0.001) were protective. At 6 months, shorter membranous urethral length (<14 mm) (OR=3.622, P<0.001), neoadjuvant hormone therapy (OR=5.783, P<0.001), and higher Gleason score (OR=2.824, P<0.001) were risk factors, while lower BMI (OR=0.317, P<0.001), smaller prostate volume (<40 mL) (OR=0.591, P=0.044), and lower CONUT score (<4) (OR=0.372, P<0.001) were protective. The nomograms showed good predictive performance, with AUCs of 0.679 at 3 months and 0.818 at 6 months.</p><p><strong>Conclusions: </strong>The developed nomograms effectively stratify the risk of urinary incontinence following RP in high-risk patients, facilitating individualized perioperative management and rehabilitation strategies.</p>\",\"PeriodicalId\":7437,\"journal\":{\"name\":\"American journal of cancer research\",\"volume\":\"15 7\",\"pages\":\"3017-3034\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-07-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344162/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of cancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.62347/ZYAA3728\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/ZYAA3728","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Development and validation of nomogram models for predicting urinary incontinence following radical prostatectomy in high-risk prostate cancer patients.
Objective: To develop a risk stratification model for predicting urinary incontinence following radical prostatectomy (RP) in high-risk prostate cancer patients based on their clinicopathological characteristics.
Methods: A retrospective analysis was conducted on 520 prostate cancer patients who underwent RP between January 2016 and January 2024. Baseline characteristics, pathological data, laboratory parameters, and surgery-related factors were collected. Urinary continence status at 1, 3, and 6 months postoperatively was assessed. Multivariate logistic regression analyses were performed to identify independent risk factors, and nomograms were constructed to predict urinary incontinence risk at each time point.
Results: Urinary incontinence rates at 1, 3, and 6 months postoperatively were 92.88%, 69.62%, and 23.65%, respectively. At 1 month, a higher Gleason score (OR=2.178, P=0.003) was a risk factor, while robot-assisted surgery was protective (OR=0.289, P=0.003). At 3 months, higher Gleason score (OR=1.565, P=0.004) increased risk, whereas lower BMI (<25 kg/m2) (OR=0.448, P=0.005) and longer preoperative membranous urethral length (≥14 mm) (OR=2.368, P<0.001) were protective. At 6 months, shorter membranous urethral length (<14 mm) (OR=3.622, P<0.001), neoadjuvant hormone therapy (OR=5.783, P<0.001), and higher Gleason score (OR=2.824, P<0.001) were risk factors, while lower BMI (OR=0.317, P<0.001), smaller prostate volume (<40 mL) (OR=0.591, P=0.044), and lower CONUT score (<4) (OR=0.372, P<0.001) were protective. The nomograms showed good predictive performance, with AUCs of 0.679 at 3 months and 0.818 at 6 months.
Conclusions: The developed nomograms effectively stratify the risk of urinary incontinence following RP in high-risk patients, facilitating individualized perioperative management and rehabilitation strategies.
期刊介绍:
The American Journal of Cancer Research (AJCR) (ISSN 2156-6976), is an independent open access, online only journal to facilitate rapid dissemination of novel discoveries in basic science and treatment of cancer. It was founded by a group of scientists for cancer research and clinical academic oncologists from around the world, who are devoted to the promotion and advancement of our understanding of the cancer and its treatment. The scope of AJCR is intended to encompass that of multi-disciplinary researchers from any scientific discipline where the primary focus of the research is to increase and integrate knowledge about etiology and molecular mechanisms of carcinogenesis with the ultimate aim of advancing the cure and prevention of this increasingly devastating disease. To achieve these aims AJCR will publish review articles, original articles and new techniques in cancer research and therapy. It will also publish hypothesis, case reports and letter to the editor. Unlike most other open access online journals, AJCR will keep most of the traditional features of paper print that we are all familiar with, such as continuous volume, issue numbers, as well as continuous page numbers to retain our comfortable familiarity towards an academic journal.